- beauty
- industrial
Mosedipimod
CAS 221139-79-3
Concern score
Mosedipimod in plain language
On cosmetic ingredient lists it appears as “Acetic/linoleic/palmitic triglyceride”.
Also known as Acetic/linoleic/palmitic triglyceride · 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol · Plag, (±)- · 1-palmitoyl-2-linoleoyl-3-acetylglycerol · AKOS040748955 · DB12592
Show all 16 names
EC-18 · EC-18 cpd · Gakunxbdvglofs-duzkargpsa-n · GLXC-25910 · Mosedipimod (USAN/INN) · PLA-racglycerol · Plag · Plag, (+/-) · UNII-88928BS57E · Who 10702
Used in cosmetics as a humectant, an emollient and a skin-conditioning agent. Acetic/Linoleic/Palmitic Triglyceride is the triester of glycerin with acetic, linoleic and palmitic acids.
- Humectant
- Emollient
- Skin conditioning
- Conditioner
- We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.
Regulation
No restrictions found. Mosedipimod appears in these published regulatory listings.
- Found in consumer products
- Industrial
EUCosIngActiveAcetic/Linoleic/Palmitic Triglyceride is the triester of glycerin with acetic, linoleic and palmitic acids.
- Acetic/Linoleic/Palmitic Triglyceride is the triester of glycerin with acetic, linoleic and palmitic acids.Source →
USEPAcommercial use observedEPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner.
- EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Expert safety opinions
No expert opinion on file for Mosedipimod. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.
SCCS
EU Scientific Committee on Consumer Safety
No SCCS opinion on file.
CIR
Cosmetic Ingredient Review (US expert panel)
No CIR safety assessment on file.
Evidence & sources
No graded research studies for Mosedipimod yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
- Open →
CosIng
regulatory · updated 2026-09-23
- Open →
EPA Chemical and Products Database
exposure · updated 2019-12-20
- Open →
EPA DSSTox Identifiers
chemistry · updated 2025-12-29
- Open →
FDA GSRS UNII
registry · updated 2026-02-26
- Open →
openFDA Substance
registry · updated 2026-05-24
- Open →
PubChem Live Enrichment
chemistry · updated 2026-05-17
Reference links (1)
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
Where it has been recorded
How often EPA CPDat has listed Mosedipimod in a product composition. These are source records, not Greenveil catalog products.
Named organisations
1
Typical roles